Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Polycystic Ovary Syndrome or PCOS affects millions of women in the United States. There is currently no standard treatment for it. Weight loss drugs l ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent ...

Despite internet rumors to the contrary, biotin doesn’t cause weight gain. There's currently no evidence suggesting that ...

Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...